Abstract
Objectives Previous data indicate that children might play a less crucial role in SARS-CoV-2 transmission than initially assumed. We conducted a study to gain further knowledge on prevalence, transmission and spread of SARS-CoV-2 among preschool children, their parents and caretakers.
Methods Children, their parents and care givers in 14 childcare facilities in Dresden, Saxony/ Germany were invited to participate in the KiTaCoviDD19-study between July 2020 and January 2021. Seroprevalence of SARS-CoV-2 antibodies was assessed up to 4 times during the study period in all participating adults and personal characteristics as well as epidemiological information of personal SARS-CoV-2 history were obtained. Stool viral shedding of SARS-CoV-2 was analyzed every 2-4 weeks in all participating children.
Results In total, 318 children, 299 parents and 233 childcare workers were enrolled. The percentage of seropositive adults and SARS-CoV-2 positive detected children rose considerably by January 2021. However, the rate of SARS-CoV-2 positive children was considerably lower than the rate of seropositive adults. Overall, we detected a maximum of three connected cases in children. About 50% of SARS-CoV-2 infections in children could not be connected to a secondary case within our study population.
Conclusion The study could not provide evidence for a relevant asymptomatic (“silent”) spread of SARS-CoV-2 in childcare facilities, neither in a low nor a high prevalence setting. This finding adds to the evidence that childcare and educational settings do not play a crucial role in driving the SARS-CoV-2 pandemic.
Table of Contents Summary This longitudinal study among children, parents and childcare workers provides further insight on SARS-CoV-2 prevalence and transmission within childcare facilities.
What’s Known on This Subject Based on age distribution of SARS-CoV-2 infections and previous data of very limited spread of COVID-19 among primary and secondary schools there is reason to believe that children play a less crucial role in SARS-CoV-2 transmission than initially assumed.
What This Study Adds Previously published studies focus mainly on SARS-CoV-2 transmission in schools. This longitudinal study provides information on prevalence, transmission and spread of SARS-CoV-2 within childcare facilities during low- and high-prevalence settings.
Competing Interest Statement
Conflict of Interest Disclosure: Alexander H. Dalpke, Reinhard Berner and Jakob P. Armann report grants from the Federal State of Saxony during the conduct of the study. The other authors have no conflicts of interest to disclose.
Clinical Trial
DRKS00022729
Funding Statement
This study was supported by a grant by the Federal State of Saxony. Role of the Funding Source: The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The KitaCoviDD19-study which was approved by the Ethics Committee of the Technische Universitaet (TU) Dresden (BO-EK-180052020)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest Disclosure: Alexander H. Dalpke, Reinhard Berner and Jakob P. Armann report grants from the Federal State of Saxony during the conduct of the study. The other authors have no conflicts of interest to disclose.
Funding: This study was supported by a grant by the Federal State of Saxony.
Role of the Funding Source: The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
Clinical Trial Registration: KiTaCoviDD19: SARS-CoV-2 Surveillance im Vorschulalter (COVID-19), DRKS00022729, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022729
Data Sharing: Deidentified individual participant data (including data dictionaries) will be made available, in addition to study protocols, the statistical analysis plan, and the informed consent form. The data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal. Proposals should be submitted to jakob.armann{at}uniklinikum-dresden.de
Contributors’ Statement: Dr Armann conceptualized and designed the study, wrote the protocol, collected samples, analyzed and verified the data, drafted the initial manuscript, and reviewed and revised the manuscript.
Ms Haag and Ms Blankenburg collected samples, analyzed and verified the data, drafted the initial manuscript, and reviewed and revised the manuscript.
Prof Berner conceptualized and designed the study, wrote the protocol, and reviewed and revised the manuscript.
Prof Dalpke conceptualized and designed the study, wrote the protocol, performed laboratory analyses, and reviewed and revised the manuscript.
Drs Lück and Büttner performed laboratory analyses, and reviewed and revised the manuscript.
Dr Galow and Ms Unrath conceptualized and designed the study, wrote the protocol, collected samples, and reviewed and revised the manuscript.
Dr Kahre, Ms Schneider and Ms Grabietz collected samples, and reviewed and revised the manuscript.
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Data Availability
Deidentified individual participant data will be made available, in addition to study protocols, the statistical analysis plan, and the informed consent form. The data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal. Proposals should be submitted to jakob.armann@uniklinikum-dresden.de
Abbreviations
- COVID-19
- Coronavirus disease 2019
- ELISA
- enzyme-linked immunosorbent assay
- IgG
- Immunoglobulin G
- IQR
- Interquartile Range
- PCR
- Polymerase Chain Reaction
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus type 2
